Inhibition of Pro-Inflammatory Phospholipase A2 by Acute Phase Proteins
Author Information
Author(s): W. Pruzanski, E. Stefanski, P. Vadas
Primary Institution: University of Toronto
Hypothesis
Do acute phase proteins interact with and inhibit the activity of secretory non-pancreatic phospholipase A2 (sPLA2)?
Conclusion
The study found that certain acute phase proteins, specifically CRP, SAP, and lactoferrin, inhibit the activity of sPLA2.
Supporting Evidence
- CRP, lactoferrin, and SAP were found to inhibit sPLA2 activity.
- CRP showed competitive inhibition against sPLA2 when using specific substrates.
- Lactoferrin was identified as the most active inhibitor among the tested proteins.
Takeaway
Some proteins in our body that help fight inflammation can stop a specific enzyme from causing more inflammation.
Methodology
The study tested ten acute phase proteins for their ability to inhibit sPLA2 activity using multilamellar liposomes as substrates.
Limitations
The study did not explore the effects of all possible acute phase proteins or the long-term implications of these interactions.
Want to read the original?
Access the complete publication on the publisher's website